28 Stocks Moving In Wednesday's Mid-Day Session

Loading...
Loading...

Gainers

  • Immuron Limited IMRN shares jumped 40.2% to $3.5887. Immuron received funding of A$6.2 ($4.45) million from the U.S Department of Defense to examine a dosing regimen for Travelan more suited for use by the military.
  • Fresh Vine Wine, Inc. VINE surged 38.3% to $6.74 after the company reported a partnership with CRAVE American Kitchen & Sushi Bar.
  • Immix Biopharma, Inc. IMMX gained 28% to $6.95 after the company announced preclinical data of its lead program, IMX-110. The data showed that IMX-110 produced a 50% response rate in first-line-therapy-resistant cancer - soft tissue sarcoma (STS) mouse study, surpassing the STS standard of care doxorubicin’s 0% response rate in the same mouse study.
  • Fathom Digital Manufacturing Corporation FATH shares climbed 26.9% to $6.74.
  • Merida Merger Corp. I MCMJ rose 18.9% to $9.98. Leafly and Merida Merger Corp. I reported a $30 million convertible note financing.
  • Kidpik Corp. PIK rose 15.7% to $7.00 after jumping more than 27% on Tuesday. Kidpik, last month, posted a Q3 loss of $0.22 per share.
  • BTCS Inc. BTCS gained 15.2% to $6.49.
  • Sonendo, Inc. SONX jumped 15% to $7.76. Sonendo recently issued Q4 and FY21 sales guidance above estimates.
  • Qutoutiao Inc. QTT gained 14.3% to $3.18. Shares of several Chinese companies traded higher following data that showed China's inflation rose slower than expected in December, which increased policy easing optimism.
  • Ebix, Inc. EBIX gained 11% to $34.47.
  • Vinco Ventures, Inc. BBIG jumped 10.1% to $2.5773.
  • Journey Medical Corporation DERM gained 10% to $6.05.
  • Jaguar Health, Inc. JAGX rose 9.7% to $1.0199 following a 13G filing from Oasis Capital showing a 9.99% stake in the company.
  • 51job, Inc. JOBS shares surged 9.4% to $50.14. 51job reported receipt of a proposal to amend merger consideration for going-private transaction.
  • inTEST Corporation INTT gained 9.2% to $13.05.
  • Planet Labs PBC PL shares rose 9.1% to $6.16 after Goldman Sachs initiated coverage on the stock with a Buy rating and a $11 price target.

Check out these big penny stock gainers and losers

Losers

  • Prothena Corporation plc PRTA shares fell 15.8% to $32.96.
  • Koninklijke Philips N.V. PHG shares dropped 15% to $32.96 after the company hiked the cost of its recall of ventilators and warned earnings would take a big hit from global supply chain shortages.
  • Aclaris Therapeutics, Inc. ACRS dipped 14.6% to $10.98. Providing a R&D update, Aclaris Therapeutics said David Gordon, its chief medical officer left the company, effective Jan. 7. The company also announced update on its two Phase 2 programs that evaluate zunsemetinib in subjects with moderate to severe rheumatoid arthritis and in subjects with moderate to severe hidradenitis suppurative.
  • Nam Tai Property Inc. NTP dropped 14.4% to $9.87. Nam Tai Property issued an update on local affairs and efforts to preserve social stability.
  • Theravance Biopharma, Inc. TBPH shares declined 12.7% to $9.74. Theravance Biopharma recently reported enrollment of first patient in YUPELRI® Phase 4 study.
  • Jefferies Financial Group Inc. JEF fell 9.7% to $37.42 after the company reported worse-than-expected Q4 sales results.
  • Phio Pharmaceuticals Corp. PHIO shares fell 9.6% to $0.9299. Phio Pharmaceuticals shares gained 8% on Tuesday after the company announced regulatory clearance of the clinical trial of PH-762 to treat melanoma.
  • ATA Creativity Global AACG fell 9.2% to $2.08.
  • Lucira Health, Inc. LHDX shares declined 8.9% to $7.33. The company recently said that its Lucira™ Check-It PCR-Quality, At-Home Molecular COVID-19 Test is now available in the Optum Store.
  • Biogen Inc. BIIB fell 8.7% to $220.53 following a U.S. Centers For Medicare listing for "Monoclonal Antibodies Directed Against Amyloid for the Treatment of Alzheimer's Disease."
  • Hour Loop, Inc. HOUR dropped 7.8% to $6.20. The company recently priced its IPO at $4 per share.
  • Wipro Limited WIT fell 7.7% to $8.77 following Q3 results. The company reported third-quarter FY22 gross revenue of $2.7 billion, an increase of 3.3% Q/Q and 29.6% Y/Y.
Loading...
Loading...
Market News and Data brought to you by Benzinga APIs
Posted In: NewsPenny StocksSmall CapIntraday UpdateMarketsMoversTrading IdeasMid-Day MoversTop Gainers
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...